RxDoctor Payments Data

Victoria Scala, MD

Foot and Ankle Surgery · Kailua Kona, HINPI 1285096255

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 31.1% of the total.

$5,477in general payments, 2019–2025

Across 68 payments — averaging $80.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Arthrex$2K
  • Paragon 28, Inc.$542
  • Johnson & Johnson$337
  • Elevate Surgical Co$305
  • Tricoast Surgical Solutions LLC$211
  • plus $699 from 8 others

What the payments were for

  • Travel & lodging$2,93454%
  • Food & beverage$2,54346%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.11$1,703
Arthrex28$1,680
Paragon 28, Inc.3$542
Johnson & Johnson3$337
Elevate Surgical Co6$305
Tricoast Surgical Solutions LLC3$211
Stryker1$146
Orthofix Medical, Inc.7$123
Medline Industries LP1$118
Trimed, Inc.1$102
Bioventus LLC1$86
Skeletal Dynamics Inc1$80
Vertex1$25
Solventum Corporation1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few foot and ankle surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$5,497
Medicare patients
21
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron24$183
Oxycodone Hcl17$63

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Kailua Kona

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →